New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentYameng Sun, Jidong Jia, Yuemin Nan et al.|Hepatology|2016Cited by 156
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Hong You, Yiwen Shi et al.|Expert Opinion on Biological Therapy|2018Cited by 44
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapyYameng Sun, Hong You, Jialing Zhou et al.|Scientific Reports|2018Cited by 43
On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in <scp>HBV</scp>‐related compensated cirrhosisShanshan Wu, Jidong Jia, Yuanyuan Kong et al.|Liver International|2017Cited by 41
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavirYuanyuan Kong, Hong You, Yameng Sun et al.|Journal of Viral Hepatitis|2019Cited by 34